No Data
Orgenesis Delays 10-K Filing Amid Financial Challenges
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening Its Regenerative Medicine Portfolio With Spinal Cord Injury Therapies
J.P. Morgan remains focused on large technology giants in Q4! A big purchase of Broadcom and Tesla, while reducing shareholding in Microsoft and Google.
According to the disclosure by the USA Securities and Exchange Commission (SEC), JPMorgan submitted the Form 13F for the fourth quarter Hold Positions ending on December 31, 2024.
Orgenesis Secures Up to $5 Million Equity Investment From Williamsburg Venture Holdings
Orgenesis Q3 EPS $(1.93) Down From $(0.12) YoY, Sales $347.00K Up From $110.00K YoY
Orgenesis 3Q Rev $347,000 Vs. $110,000 >ORGS
